Bactericidal and antibiotic synergistic effect of nanosilver against methicillin-resistant staphylococcus aureus

Jundishapur Journal of Microbiology

Volumn 8, Issue 11, 2015, Pages 1-6

  Rahim, Khalid Ali Abdel ^b   Mohamed, Ahmed Mohamed Ali ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Sohag University   (Egypt)

^c IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Ag NPs; Antibiotics; Methicillin Resistant Staphylococcus aureus; Nanosilver

Indexed keywords

AMPICILLIN; CEFALEXIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; SILVER NANOPARTICLE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BIOFILM; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN;

EID: 84949551262     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.25867     Document Type: Article

References (33)

1. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004; 10(12 Suppl): S122-9. doi: 10. 1038/nm1145. [PubMed: 15577930].
2. Lim SM, Webb SA. Nosocomial bacterial infections in Intensive Care Units. I: Organisms and mechanisms of antibiotic resistance. Anaesthesia. 2005; 60(9): 887-902. doi: 10. 1111/j. 1365-2044. 2005. 04220. x. [PubMed: 16115251].
3. World Health Organization. Monitoring of Antimicrobial Resistance. Tamil Nadu: 2003.
4. Erami M, Soltani B, Taghavi Ardakani A, Moravveji A, Haji Rezaei M, Soltani S, et al. Nasal Carriage and Resistance Pattern of Multidrug Resistant Staphylococcus aureus Among Healthy Children in Kashan, Iran. Iran Red Crescent Med J. 2014; 16(10): 21346. doi: 10. 5812/ircmj. 21346.
5. Motevasel M, Okhovat MA, Zomorodian K, Farshad S. A Study of the Effect of Zataria multiflora Extract on Methicillin Resistant Staphylococcus aureus. Jundishapur J Microbiol. 2013; 6(5). doi: 10. 5812/jjm. 5453.
6. Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, et al. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol. 2005; 3(6): 1-10. doi: 10. 1186/1477-3155-3-6.
7. Hwang IS, Lee J, Hwang JH, Kim KJ, Lee DG. Silver nanoparticles induce apoptotic cell death in Candida albicans through the increase of hydroxyl radicals. FEBS J. 2012; 279(7): 1327-38. doi: 10. 1111/j. 1742-4658. 2012. 08527. x. [PubMed: 22324978].
8. Martínez-Castañón GA, Niño-Martínez N, Martínez-Gutierrez F, Martínez-Mendoza JR, Ruiz F. Synthesis and antibacterial activity of silver nanoparticles with different sizes. J Nanoparticle Res. 2008; 10(8): 1343-8. doi: 10. 1007/s11051-008-9428-6.
9. Lynch SV, Dixon L, Benoit MR, Brodie EL, Keyhan M, Hu P, et al. Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms. Antimicrob Agents Chemother. 2007; 51(10): 3650-8. doi: 10. 1128/AAC. 00601-07. [PubMed: 17664315].
10. Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis. 1998; 26(5): 1179-81. [PubMed: 9597249].
11. Paju S, Scannapieco FA. Oral biofilms, periodontitis, and pulmonary infections. Oral Dis. 2007; 13(6): 508-12. doi: 10. 1111/j. 1601-0825. 2007. 01410a. x. [PubMed: 17944664].
12. Hojo K, Nagaoka S, Ohshima T, Maeda N. Bacterial interactions in dental biofilm development. J Dent Res. 2009; 88(11): 982-90. doi: 10. 1177/0022034509346811. [PubMed: 19828884].
13. Palmer J. Bacterial biofilms in chronic rhinosinusitis. Ann Otol Rhinol Laryngol Suppl. 2006; 196: 35-9. [PubMed: 17040016].
14. Lau GW, Hassett DJ, Britigan BE. Modulation of lung epithelial functions by Pseudomonas aeruginosa. Trends Microbiol. 2005; 13(8): 389-97. doi: 10. 1016/j. tim. 2005. 05. 011. [PubMed: 15951179].
15. Wagner VE, Iglewski BH. P. aeruginosa Biofilms in CF Infection. Clin Rev Allergy Immunol. 2008; 35(3): 124-34. doi: 10. 1007/s12016-008-8079-9. [PubMed: 18509765].
16. Khardori N, Yassien M. Biofilms in device-related infections. J Ind Microbiol. 1995; 15(3): 141-7. [PubMed: 8519469].
17. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007; 130(5): 797-810. doi: 10. 1016/j. cell. 2007. 06. 049. [PubMed: 17803904].
18. Clinical and Laboratory Standards Institute. Informational Supplement. Wayne, Pennsylvania: CLSI Document M100-S16; 2006.
19. Gurunathan S, Han JW, Kwon DN, Kim JH. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res Lett. 2014; 9(1): 373. doi: 10. 1186/1556-276X-9-373. [PubMed: 25136281].
20. Antunes AL, Trentin DS, Bonfanti JW, Pinto CC, Perez LR, Macedo AJ, et al. Application of a feasible method for determination of biofilm antimicrobial susceptibility in staphylococci. APMIS. 2010; 118(11): 873-7. doi: 10. 1111/j. 1600-0463. 2010. 02681. x. [PubMed: 20955460].
21. Wei GX, Campagna AN, Bobek LA. Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother. 2006; 57(6): 1100-9. doi: 10. 1093/jac/dkl120. [PubMed: 16595638].
22. Caufield PW, Dasanayake AP, Li Y, Pan Y, Hsu J, Hardin JM. Natural history of Streptococcus sanguinis in the oral cavity of infants: evidence for a discrete window of infectivity. Infect Immun. 2000; 68(7): 4018-23. [PubMed: 10858217].
23. Singh M, Singh S, Prasad S, Gambhir IS. Nanotechnology in medicine and antibacterial effect of silver nanoparticles. Digest J Nanomater Biostructures. 2008; 3(3): 115-22.
24. Orji JO. Antibacterial efficacy of colloidal silver alone and in combination with other antibiotics on isolates from wound Infections. Sci Res Essays. 2007; 2(8): 338-41.
25. Kim SH, Lee HS, Ryu DS, Choi SJ, Lee DS. Antibacterial activity of silver-nanoparticles against Staphylococcus aureus and Escherichia coli. Korean J Microbiol Biotechnol. 2011; 39(1): 77-85.
26. Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomedicine. 2010; 6(1): 103-9. doi: 10. 1016/j. nano. 2009. 04. 006. [PubMed: 19447203].
27. Rai MK, Deshmukh SD, Ingle AP, Gade AK. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J Appl Microbiol. 2012; 112(5): 841-52. doi: 10. 1111/j. 1365-2672. 2012. 05253. x. [PubMed: 22324439].
28. Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine. 2007; 3(2): 168-71. doi: 10. 1016/j. nano. 2007. 02. 001. [PubMed: 17468052].
29. Oni AA, Nwaorgu OGB, Bakare RA, Ogunkunle MO, Toki RA. The Discharging Ears In Adults In Ibadan, Nigeria Causative Agents And Antimicrobial Sensitivity Pattern. Afr J Clin Exp Microbiol. 2002; 3(1). doi: 10. 4314/ajcem. v3i1. 7341.
30. Marshall CR, Killoh GB. The Bactericidal Action of Collosols of Silver and Mercury. Br Med J. 1915; 1(2820): 102-4. [PubMed: 20767445].
31. Costerton JW, Irvin RT, Cheng KJ. The bacterial glycocalyx in nature and disease. Annu Rev Microbiol. 1981; 35: 299-324. doi: 10. 1146/annurev. mi. 35. 100181. 001503. [PubMed: 7027902].
32. Costerton JW, Lappin-Scott HM. Introduction to microbial biofilms. Microbial Biofilms. 1995: 1-11.
33. Monroe D. Looking for chinks in the armor of bacterial biofilms. PLoS Biol. 2007; 5(11): e307. doi: 10. 1371/journal. pbio. 0050307. [PubMed: 18001153].